Zeng R, Luo DX, Li HP, Zhang QS, Lei SS, Chen JH (2019) MicroRNA-135b alleviates MPP+-mediated Parkinsons disease in in vitro model through suppressing FoxO1-induced NLRP3 inflammasome and pyroptosis
Meanwhile, dual agonists, which target and activate both the GLP-1 (Glucagon-like peptide-1) receptor and the GIP (glucose-dependent insulinotropic polypeptide) receptor, and triple agonists (targeting the GLP-1+GIP+Glucagon receptors) are also showing promise
Serious side effects requiring immediate medical attention include: Symptoms of acute pancreatitis (severe abdominal pain, sometimes radiating to the back) Signs of gallbladder problems (pain in the right upper abdomen, fever, yellowing of skin/eyes) Severe vomiting or diarrhoea leading to dehydration Sudden vision changes (which may indicate worsening diabetic retinopathy) Signs of serious allergic reactions (breathing difficulties, swelling of face/throat, severe rash) Other notable side effects include injection site reactions (redness, itching, or swelling at the injection site), fatigue, and hypoglycaemia, particularly when Mounjaro is used in combination with insulin or sulfonylureas
The proposed peptide mapping method using UPLC-HRMS was useful for determining active ingredient sameness between generic synthetic peptides and previously approved peptide drug products of rDNA origin
Biomed Pharmacother 2022;147:112659